{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:33:38Z","timestamp":1790264018995,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015828","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T06:40:20Z","timestamp":1731998420000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Vaccines for preventing Ebola virus disease"],"prefix":"10.1002","volume":"2024","author":[{"given":"Rebecca","family":"Kuehn","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Ryan","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology; Royal Liverpool University Hospital; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C","family":"Okwaraeke","sequence":"additional","affiliation":[{"name":"Research; The Alliance for International Medical Action (ALIMA); Owo Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Gould","sequence":"additional","affiliation":[{"name":"Royal Liverpool University Hospital; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marty","family":"Chaplin","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Riley","sequence":"additional","affiliation":[{"name":"Royal Liverpool University Hospital; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Turtle","sequence":"additional","affiliation":[{"name":"NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences; University of Liverpool; Liverpool UK"},{"name":"The Pandemic Institute; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shevin T","family":"Jacob","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD015828-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1056\/NEJMoa1411249","article-title":"Clinical presentation of patients with Ebola virus disease in Conakry, Guinea","volume":"372","author":"Bah","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD015828-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines. 3: rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015828-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015828-BIB0004|cit4","unstructured":"Centers for Disease Control and Prevention (CDC) National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) Ebola Disease Available at www.cdc.gov\/vhf\/ebola\/index.html"},{"issue":"6","key":"10.1002\/14651858.CD015828-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1473-3099(23)00819-8","article-title":"Case fatality risk among individuals vaccinated with rVSV\u0394G-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo","volume":"24","author":"Coulborn","year":"2024","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD015828-BIB0006|cit6","unstructured":"Covidence Veritas Health Innovation 2024"},{"key":"10.1002\/14651858.CD015828-BIB0007|cit7","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from www.training.cochrane.org\/handbook 2023"},{"issue":"3","key":"10.1002\/14651858.CD015828-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/21645515.2016.1238535","article-title":"Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: an open phase I\/II trial in healthy adults in Russia","volume":"13","author":"Dolzhikova","year":"2017","journal-title":"Human Vaccines and Immunotherapeutics"},{"key":"10.1002\/14651858.CD015828-BIB0009|cit9","unstructured":"Eldridge S Campbell MK Campbell MJ Drahota AK Giraudeau B Reeves BC Revised Cochrane risk of bias tool for randomized trials (RoB 2). Additional considerations for cluster-randomized trials (RoB 2 CRT). 18 March 2021 Available from www.riskofbias.info\/welcome\/rob-2-0-tool\/rob-2-for-cluster-randomized-trials 1 22"},{"key":"10.1002\/14651858.CD015828-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.puhe.2016.10.020","article-title":"The health impact of the 2014-15 Ebola outbreak","volume":"143","author":"Elston","year":"2017","journal-title":"Public Health"},{"key":"10.1002\/14651858.CD015828-BIB0011|cit11","unstructured":"European Medicines Agency (EMA) Zabdeno: European public assessment reports Available at ema.europa.eu\/en\/medicines\/human\/EPAR\/zabdeno"},{"key":"10.1002\/14651858.CD015828-BIB0012|cit12","unstructured":"European Medicines Agency (EMA) Mvabea: European public assessment reports Available at ema.europa.eu\/en\/medicines\/human\/EPAR\/mvabea"},{"key":"10.1002\/14651858.CD015828-BIB0013|cit13","unstructured":"European Medicines Agency (EMA) Ervebo (updated 20 February 2024) Available at www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ervebo"},{"key":"10.1002\/14651858.CD015828-BIB0014|cit14","unstructured":"Ervebo (updated 8 September 2023) Available at www.fda.gov\/vaccines-blood-biologics\/ervebo"},{"issue":"9","key":"10.1002\/14651858.CD015828-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"e683","DOI":"10.1016\/S2666-5247(22)00123-9","article-title":"Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis","volume":"3","author":"Gao","year":"2022","journal-title":"Lancet Microbe"},{"issue":"9","key":"10.1002\/14651858.CD015828-BIB0016|cit16","first-page":"442\u20138","article-title":"Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis","volume":"72","author":"Goeijenbier","year":"2014","journal-title":"Netherlands Journal of Medicine"},{"key":"10.1002\/14651858.CD015828-BIB0017|cit17","unstructured":"Higgins JPT Savovi\u0107 J Page MJ on behalf of the RoB2 Development Group Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) Available at www.riskofbias.info\/welcome\/rob-2-0-tool\/current-version-of-rob-2 2019 (accessed 23 July 2024)"},{"key":"10.1002\/14651858.CD015828-BIB0018|cit18","unstructured":"Higgins JP Li T Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from training.cochrane.org\/handbook\/current\/chapter-06"},{"key":"10.1002\/14651858.CD015828-BIB0019|cit19","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from training.cochrane.org\/handbook\/current\/chapter-08"},{"issue":"10121","key":"10.1002\/14651858.CD015828-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0140-6736(17)31795-6","article-title":"Evidence-based guidelines for supportive care of patients with Ebola virus disease","volume":"391","author":"Lamontagne","year":"2018","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015828-BIB0021|cit21","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from training.cochrane.org\/handbook\/current\/chapter-04"},{"issue":"393","key":"10.1002\/14651858.CD015828-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","article-title":"Ebola virus disease","volume":"18","author":"Malvy","year":"2019","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD015828-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"350333","DOI":"10.3389\/fimmu.2018.01025","article-title":"Herd immunity to ebola viruses is not a realistic target for current vaccination strategies","volume":"9","author":"Masterson","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"10.1002\/14651858.CD015828-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/heapol\/czw055","article-title":"Healthcare providers on the frontlines: a qualitative investigation of the social and emotional impact of delivering health services during Sierra Leone's Ebola epidemic","volume":"31","author":"McMahon","year":"2016","journal-title":"Health Policy and Planning"},{"issue":"24","key":"10.1002\/14651858.CD015828-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD015828-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"134","author":"Page","year":"2021","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015828-BIB0027|cit27","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD015828-BIB0028|cit28","unstructured":"Sch\u00fcnemann HJ Higgins JPT Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from training.cochrane.org\/handbook\/current\/chapter-14"},{"key":"10.1002\/14651858.CD015828-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD015828-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/S1473-3099(16)00077-3","article-title":"Sequelae of Ebola virus disease: the emergency within the emergency","volume":"16","author":"Vetter","year":"2016","journal-title":"Lancet Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD015828-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"1341\u201350","DOI":"10.1513\/AnnalsATS.201410-481PS","article-title":"Clinical presentation and management of severe Ebola virus disease","volume":"11","author":"West","year":"2014","journal-title":"Annals of the American Thoracic Society"},{"key":"10.1002\/14651858.CD015828-BIB0032|cit32","unstructured":"World Health Organization (WHO) Ebola virus disease (Factsheet). April 2023 Available from who.int\/news-room\/fact-sheets\/detail\/ebola-virus-disease"},{"issue":"12","key":"10.1002\/14651858.CD015828-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"e1010078","DOI":"10.1371\/journal.ppat.1010078","article-title":"Current state of Ebola virus vaccines: a snapshot","volume":"17","author":"Woolsey","year":"2021","journal-title":"PLOS Pathogens"},{"issue":"9984","key":"10.1002\/14651858.CD015828-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1016\/S0140-6736(15)60553-0","article-title":"Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"385","author":"Zhu","year":"2015","journal-title":"Lancet"},{"issue":"10069","key":"10.1002\/14651858.CD015828-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","article-title":"Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"389","author":"Zhu","year":"2017","journal-title":"Lancet"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T06:40:38Z","timestamp":1731998438000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015828"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015828","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]}}}